Skip to content

Quinidine

Quinidex (quinidine) is a small molecule pharmaceutical. Quinidine was first approved as Quinidex on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. It is known to target potassium channel subfamily U member 1, potassium voltage-gated channel subfamily H member 1, potassium voltage-gated channel subfamily H member 5, potassium voltage-gated channel subfamily A member 5, equilibrative nucleoside transporter 4, potassium voltage-gated channel subfamily A member 7, potassium channel subfamily K member 5, potassium channel subfamily T member 1, potassium channel subfamily T member 2, potassium channel subfamily K member 18, potassium channel subfamily K member 6, potassium channel subfamily K member 16, potassium channel subfamily K member 10, potassium voltage-gated channel subfamily A member 4, sodium channel protein type 5 subunit alpha, potassium voltage-gated channel subfamily D member 2, and cytochrome P450 2D6.
Trade Name Quinidex
Common Name Quinidine
Indication atrial fibrillation, atrial flutter, cardiac arrhythmias
Drug Class
Quinidine
Get full access now